stella
beta
Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC. — Stella
Recruiting
Back to Breast Cancer trials
Trial locations
(1 site)
China
Hunan Cancer Hospital, Changsha, Hunan
View full record on ClinicalTrials.gov